FilingIndex
← The Wire
BYSINasdaq

BeyondSpring Inc.

Pharmaceutical Preparations · CIK 1677940

BeyondSpring Inc. develops and commercializes novel cancer therapies using its Targeted Protein Degradation (TPD) platform

red 8-K · 90d
$65M
Market cap
$1.79
Last close
+5.9%
1D
+10.8%
5D
48K
Volume
Price · last 39 sessions+18.5%
May 4L $1.29 · H $1.79Jun 29
131
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-K/AExecutive ChangeJun 29, 20268-KExecutive Change · Reg FD DisclosureJun 4, 202610-QFORM 10-QMay 13, 20268-KResults of OperationsMay 13, 202610-KFORM 10-KMar 25, 20268-KResults of OperationsMar 25, 20268-KCompany UpdateDec 15, 20258-KMaterial AgreementNov 21, 2025424B5424B5Nov 17, 202510-QFORM 10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KMaterial Agreement · Company UpdateSep 23, 20258-KShareholder VoteSep 16, 202510-QFORM 10-QAug 13, 20258-KResults of OperationsAug 13, 2025DEF 14ADEF 14AAug 6, 2025DEFA14AFORM DEFA14AAug 6, 20258-KCompany UpdateJul 3, 202510-QFORM 10-QMay 12, 20258-KResults of OperationsMay 12, 20258-KAuditor ChangeApr 11, 202510-KFORM 10-KMar 27, 20258-KResults of OperationsMar 27, 20258-KAcquisition / Disposition · Company UpdateFeb 25, 20258-KMaterial Agreement · Company UpdateJan 28, 20258-KReg FD DisclosureJan 3, 20256-KFORM 6-KAug 29, 20246-K6-KAug 6, 20246-KFORM 6-KJun 12, 2024424B5424B5Jun 12, 202420-FFORM 20-FApr 29, 20246-K6-KMar 18, 20246-K6-KFeb 26, 20246-KFORM 6-KFeb 2, 20246-K6-KJan 16, 20246-K6-KJan 10, 20246-K6-KDec 18, 20236-K6-KOct 30, 20236-K6-KOct 4, 20236-K6-KSep 20, 20236-K6-KJul 14, 20236-K6-KMay 12, 20236-K6-KApr 18, 202320-FFORM 20-FApr 18, 20236-K6-KMar 14, 20236-KFORM 6-KFeb 28, 20236-K6-KFeb 24, 20236-K6-KJan 9, 20236-K6-KDec 30, 20226-K6-KNov 23, 20226-K6-KAug 29, 20226-K6-KJun 13, 20226-K6-KJun 9, 20226-K6-KApr 22, 202220-FFORM 20-FApr 14, 2022SC 13GSC 13GFeb 14, 20226-K6-KJan 11, 20226-KFORM 6-KDec 30, 20216-K6-KDec 27, 20216-K6-KDec 1, 20216-K6-KNov 10, 20216-K6-KSep 21, 20216-KFORM 6-KSep 10, 20216-K6-KAug 26, 20216-K6-KAug 5, 20216-K6-KAug 4, 20216-K6-KJul 14, 20216-K6-KJun 16, 202120-F20-FApr 30, 20216-K6-KApr 1, 20216-K6-KMar 19, 20216-K6-KMar 16, 20216-KFORM 6-KFeb 9, 2021SC 13GSEC SCHEDULE 13GFeb 8, 20216-K6-KDec 18, 20206-KFORM 6-KNov 23, 2020424B5424B5Nov 19, 2020424B5424B5Nov 17, 20206-K6-KNov 17, 20206-KFORM 6-KNov 16, 2020

Insider Activity

In the 90 days to Oct 17, 2025: 4 sold $561K.

DateInsiderActionSharesPriceValue
Oct 17, 2025Decheng Capital China Life Sciences Usd Fund Ii, L.P.TenPercentOwnerSell45,513$1.76$80K
Oct 16, 2025Decheng Capital China Life Sciences Usd Fund Ii, L.P.TenPercentOwnerSell85,798$1.72$148K
Oct 15, 2025Decheng Capital Global Healthcare Gp, LlcTenPercentOwnerSell17,960$1.65$30K
Oct 14, 2025Decheng Capital Global Healthcare Gp, LlcTenPercentOwnerSell28,495$1.65$47K
Oct 13, 2025Decheng Capital Global Healthcare Gp, LlcTenPercentOwnerSell107,361$1.70$183K
Oct 10, 2025Decheng Capital Global Healthcare Gp, LlcTenPercentOwnerSell2,390$1.77$4K
Oct 9, 2025Decheng Capital Global Healthcare Gp, LlcTenPercentOwnerSell3,979$1.81$7K
Oct 8, 2025Decheng Capital Global Healthcare Gp, LlcTenPercentOwnerSell7,507$1.77$13K
Oct 7, 2025Decheng Capital Management Iii (Cayman), LlcTenPercentOwnerSell2,100$1.79$4K
Oct 6, 2025Decheng Capital Management Iii (Cayman), LlcTenPercentOwnerSell17,500$1.78$31K
Oct 3, 2025Decheng Capital Management Iii (Cayman), LlcTenPercentOwnerSell600$1.76$1K
Oct 2, 2025Cui XiangminTenPercentOwnerSell600$1.73$1K
Oct 1, 2025Cui XiangminTenPercentOwnerSell2,601$1.80$5K
Sep 30, 2025Cui XiangminTenPercentOwnerSell4,464$1.81$8K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance